Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-017652
Filing Date
2024-04-03
Accepted
2024-04-03 17:02:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20021839x2_defa14a.htm DEFA14A 9422
2 ny20021839x2_nc01.jpg GRAPHIC 1036691
3 ny20021839x2_nc02.jpg GRAPHIC 1566135
  Complete submission text file 0001140361-24-017652.txt   3593965
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40407 | Film No.: 24819836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)